PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Nyse  -  04:00 2022-08-15 pm EDT
41.86 USD   -0.02%
08/09PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
08/09Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ended July 02, 2022
CI
08/09Perrigo Cuts Full-Year Profit View on Currency Headwinds After Mixed Second-Quarter Results
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Perrigo Company plc Promotes Alison Ives to Executive Vice President and Chief Scientific Officer

06/02/2022 | 10:34am EDT

Perrigo Company plc announced that Ms. Alison Ives has been promoted to Executive Vice President and Chief Scientific Officer. In this role, Ms. Ives will be responsible for providing global oversight and coordination of Perrigo's research and development, regulatory and innovation efforts. She will join the Company's Operating Committee and report to President and Chief Executive Officer, Murray S. Kessler. Ms. Ives, who joined Perrigo through the acquisition of Omega Pharma in 2015, previously worked for 11 years with AstraZeneca in a variety of regional and global leadership roles within the Scientific office, while sitting on New Product Development Teams across five therapeutic areas. Early in her career, she worked as a laboratory biochemist, researching drug discovery targets before making the move into industry. In 2021, Ms. Ives received a prestigious MBE award from the UK government for services to healthcare, reflecting her lifelong passion to make lives better.


© S&P Capital IQ 2022
All news about PERRIGO COMPANY PLC
08/09PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
08/09Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ende..
CI
08/09Perrigo Cuts Full-Year Profit View on Currency Headwinds After Mixed Second-Quarter Res..
MT
08/09PERRIGO : REPORTS SECOND QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERAT..
PU
08/09TRANSCRIPT : Perrigo Company plc, Q2 2022 Earnings Call, Aug 09, 2022
CI
08/09Perrigo Company Reports Lower Q2 Earnings, Higher Sales; Revises Full Year Guidance
MT
08/09PERRIGO : Q2 Earnings Snapshot
AQ
08/09Perrigo Company Revised Earnings Guidance for the Full Year of 2022
CI
08/09Earnings Flash (PRGO) PERRIGO COMPANY Posts Q2 Revenue $1.12B
MT
08/09Earnings Flash (PRGO) PERRIGO COMPANY Posts Q2 Loss $-0.48
MT
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Financials (USD)
Sales 2022 4 527 M - -
Net income 2022 - - -
Net Debt 2022 3 689 M - -
P/E ratio 2022 -
Yield 2022 2,58%
Capitalization 5 632 M 5 632 M -
EV / Sales 2022 2,06x
EV / Sales 2023 1,88x
Nbr of Employees 9 900
Free-Float 99,4%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 41,86 $
Average target price 50,00 $
Spread / Average Target 19,4%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Eduardo Guarita Bezerra Chief Financial Officer & Executive Vice President
Orlando D. Ashford Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC7.61%5 632
JOHNSON & JOHNSON-2.91%436 680
ELI LILLY AND COMPANY13.66%298 298
PFIZER, INC.-15.75%279 215
ROCHE HOLDING AG-16.14%277 502
ABBVIE INC.5.09%251 582